Bluejay Diagnostics, Inc. (BJDX) Misses Q3 EPS by 200c

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) reported Q3 EPS of ($2.08), $2.00 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Bluejay Diagnostics, Inc. (BJDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Accenture downgraded by TD Cowen on AI concerns
• C.H. Robinson acquires DeSpir Logistics for $75 million